CACassian Afting

Cassian Afting

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cassian Afting has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Simulation-Trained Deep Learning for Automated Cell-Based HLA Antibody Assay Interpretation in Pre-Transplant Diagnostics

    by Cassian Afting, Anna-Lena Semmler, Salim Oulghazi, Julia I. Ries, Anouk E. Lichtenberg, Julius Fe Jaeger, Christina Merk, Daniel Fuerst, Hanns-Martin Lorenz, Torsten Tonn, et al.

    Preformed and de novo antibodies against donor human leukocyte antigen (HLA) antigens remain a major cause of antibody-mediated rejection and graft loss after organ transplantation. Although solid-phase assays and virtual crossmatching have reshaped pre-transplant risk assessment, physical crossmatching, which assesses whether recipient antibodies react with donor cells, remains widely used as the final compatibility assessment before transplantation. These workflows include both complement-dependent cytotoxicity (CDC) and flow cytometry crossmatch (FCXM) assays, but their interpretation remains partly manual, operator-dependent, and, for microscopic CDC readout, semi-quantitative. Here, we present AlloViewer, a web-based software platform for automated and traceable interpretation of image-based and flow-cytometry-based HLA antibody diagnostics. For CDC microscopy, AlloViewer employs a simulation-trained deep learning (UNet) workflow that combines automated lymphocyte segmentation with experiment-specific fluorescence classification and well-level cytotoxicity scoring. To deliberately capture the technical variability encountered in routine diagnostics, we generated simulated CDC-like training images spanning differences in image resolution, acquisition conditions, staining quality, cell density, cell distribution, clustering, and background fluorescence, among others. The resulting simulation-trained model enabled robust lymphocyte detection across heterogeneous imaging conditions and outperformed a conventional rule-based image analysis pipeline under variable acquisition conditions. Automated CDC scoring achieved performance within the range of human inter-annotator variability and approached the practical reproducibility limit defined by human disagreement. To cover all modalities of pre-transplant physical crossmatching, AlloViewer further supports automated FCXM interpretation through cell population identification and population-specific immunoglobulin G (IgG) readouts. The platform integrates these workflows in an assay-specific web interface and provides application programming interface (API) access for programmatic submission of assay data and retrieval of processed results. Together, AlloViewer establishes an integrated computational framework for standardized and traceable interpretation of CDC crossmatch assays, CDC-based HLA antibody identification testing using commercial test-cell panels, and FCXM workflows. More broadly, this work demonstrates how simulation-trained artificial intelligence (AI) can facilitate robust computational analysis across technically heterogeneous laboratory environments, providing a framework for standardizing traditionally operator-dependent diagnostic workflows.

  • Open Access

    Hepatitis E virus replication is maintained in proliferative cells within the intestinal crypt

    by Sarah Prallet, Niclas Maier, Albert Li, Cassian Afting, Hao-En Huang, Jungen Hu, Elif Toprak, Deb Purna Keya, Ombretta Colasanti, Nancy León-Janampa, et al.

    The hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide. Although most infections are self-limiting, zoonotic genotypes can persist in immunocompromised individuals. Transmitted via the fecal-oral route, HEV has been suggested to directly infect the intestinal epithelium, a tissue with high regenerative capacity. Here, we demonstrate that HEV predominantly infects proliferative transit-amplifying and intestinal stem cells within the crypts of human pluripotent stem cell–derived intestinal organoids (hIOs). Supporting this, we detected HEV RNA in the intestinal crypts of an HEV-infected patient. We further found that HEV infection spreads through cell division and is maintained in hIOs for more than 40 days, contrasting with acute hepatitis A virus, whose infections are rapidly cleared from hIOs. Given the self-renewal ability and metabolic constraints of proliferative intestinal progenitor cells, our findings suggest that intestinal crypts could serve as reservoirs for chronic HEV infection and highlight the intestinal crypt as a primary target for viral infection in the gastrointestinal tract.


  • Open Access

    Deep learning predicts tissue outcomes in retinal organoids

    by Cassian Afting, Norin Bhatti, Christina Schlagheck, Encarnación Sánchez Salvador, Laura Herrera-Astorga, Rashi Agarwal, Risa Suzuki, Nicolaj Hackert, Hanns-Martin Lorenz, Lucie Zilova, et al.

    Retinal organoids have become important models for studying development and disease, yet stochastic heterogeneity in the formation of cell types, tissues, and phenotypes remains a major challenge. This limits our ability to precisely experimentally address the early developmental trajectories towards these outcomes. Here, we utilize deep learning to predict the differentiation path and resulting tissues in retinal organoids well before they become visually discernible. Our approach effectively bypasses the challenge of organoid-related heterogeneity in tissue formation. For this, we acquired a high-resolution time-lapse imaging dataset comprising about 1,000 organoids and over 100,000 images enabling precise temporal tracking of organoid development. By combining expert annotations with advanced image analysis of organoid morphology, we characterized the heterogeneity of the retinal pigmented epithelium (RPE) and lens tissues, as well as global organoid morphologies over time. Using this training set, our deep learning approach accurately predicts the emergence and size of RPE and lens tissue formation on an organoid-by-organoid basis at early developmental stages, refining our understanding of when early lineage decisions are made. This approach advances knowledge of tissue and phenotype decision-making in organoid development and can inform the design of similar predictive platforms for other organoid systems, paving the way for more standardized and reproducible organoid research. Finally, it provides a direct focus on early developmental time points for in-depth molecular analyses, alleviated from confounding effects of heterogeneity.


  • Open Access

    DNA microbeads for spatio-temporally controlled morphogen release within organoids

    by Cassian Afting, Tobias Walther, Oliver M. Drozdowski, Christina Schlagheck, Ulrich S. Schwarz, Joachim Wittbrodt, Kerstin Göpfrich

    Organoids are transformative in vitro model systems that mimic features of the corresponding tissue in vivo. However, across tissue types and species, organoids still often fail to reach full maturity and function because biochemical cues cannot be provided from within the organoid to guide their development. Here we introduce nanoengineered DNA microbeads with tissue mimetic tunable stiffness for implementing spatio-temporally controlled morphogen gradients inside of organoids at any point in their development. Using medaka retinal organoids and early embryos, we show that DNA microbeads can be integrated into embryos and organoids by microinjection and erased in a non-invasive manner with light. Coupling a recombinant surrogate Wnt to the DNA microbeads, we demonstrate the spatio-temporally controlled morphogen release from the microinjection site, which leads to morphogen gradients resulting in the formation of retinal pigmented epithelium while maintaining neuroretinal cell types. Thus, we bioengineered retinal organoids to more closely mirror the cell type diversity of in vivo retinae. Owing to the facile, one-pot fabrication process, the DNA microbead technology can be adapted to other organoid systems for improved tissue mimicry.


  • Open Access

    Minimal‐Invasive 3D Laser Printing of Microimplants in Organismo

    by Cassian Afting, Philipp Mainik, Clara Vazquez‐Martel, Tobias Abele, Verena Kaul, Girish Kale, Kerstin Göpfrich, Steffen Lemke, Eva Blasco, Joachim Wittbrodt

    Multi‐photon 3D laser printing has gathered much attention in recent years as a means of manufacturing biocompatible scaffolds that can modify and guide cellular behavior in vitro. However, in vivo tissue engineering efforts have been limited so far to the implantation of beforehand 3D printed biocompatible scaffolds and in vivo bioprinting of tissue constructs from bioinks containing cells, biomolecules, and printable hydrogel formulations. Thus, a comprehensive 3D laser printing platform for in vivo and in situ manufacturing of microimplants raised from synthetic polymer‐based inks is currently missing. Here, a platform for minimal‐invasive manufacturing of microimplants directly in the organism is presented by one‐photon photopolymerization and multi‐photon 3D laser printing. Employing a commercially available elastomeric ink giving rise to biocompatible synthetic polymer‐based microimplants, first applicational examples of biological responses to in situ printed microimplants are demonstrated in the teleost fish Oryzias latipes and in embryos of the fruit fly Drosophila melanogaster. This provides a framework for future studies addressing the suitability of inks for in vivo 3D manufacturing. The platform bears great potential for the direct engineering of the intricate microarchitectures in a variety of tissues in model organisms and beyond.


  • Open Access

    Minimal-invasive 3D laser printing of microimplants in organismo

    by Cassian Afting, Philipp Mainik, Clara Vazquez-Martel, Tobias Abele, Verena Kaul, Kerstin Göpfrich, Steffen Lemke, Eva Blasco, Joachim Wittbrodt

    Multi-photon 3D laser printing has gathered much attention in recent years as a means of manufacturing biocompatible scaffolds that can modify and guide cellular behavior in vitro . However, in vivo tissue engineering efforts have been limited so far to the implantation of beforehand 3D printed biocompatible scaffolds and in vivo bioprinting of tissue constructs from bioinks containing cells, biomolecules, and printable hydrogel formulations. Thus, a comprehensive 3D laser printing platform for in vivo and in situ manufacturing of microimplants raised from synthetic polymer-based inks is currently missing. Here we present a platform for minimal-invasive manufacturing of microimplants directly in the organism by one-photon photopolymerization and multi-photon 3D laser printing. Employing a commercially available elastomeric ink giving rise to biocompatible synthetic polymer-based microimplants, we demonstrate first applicational examples of biological responses to in situ printed microimplants in the teleost fish Oryzias latipes and in embryos of the fruit fly Drosophila melanogaster . This provides a framework for future studies addressing the suitability of inks for in vivo 3D manufacturing. Our platform bears great potential for the direct engineering of the intricate microarchitectures in a variety of tissues in model organisms and beyond.